Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study of ATI-2042 in Patients With Paroxysmal Atrial Fibrillation and Pacemakers With Atrial Fibrillation Data Logging Capabilities

NCT00389792 is registered in ClinicalTrials.gov with ARYx Therapeutics as lead sponsor.

NCT NCT00389792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00389792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study of ATI-2042 in Patients With Paroxysmal Atrial Fibrillation and Pacemakers With Atrial Fibrillation Data Logging Capabilities
Lead sponsor
ARYx Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2006
Completion date
December 31, 2008
Enrollment
72 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation